Richard Moscicki

2.3k total citations
29 papers, 1.4k citations indexed

About

Richard Moscicki is a scholar working on Neurology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Richard Moscicki has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Richard Moscicki's work include Vestibular and auditory disorders (8 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Richard Moscicki is often cited by papers focused on Vestibular and auditory disorders (8 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Richard Moscicki collaborates with scholars based in United States, Singapore and Canada. Richard Moscicki's co-authors include Kurt J. Bloch, J T Kurnick, R B Colvin, Joseph Zabner, Steven D. Rauch, Gordon B. Hughes, Stephen M. Krane, Edward P. Amento, Rosemary Balfour and Ronald L. Gibson and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Richard Moscicki

29 papers receiving 1.4k citations

Peers

Richard Moscicki
Matt Lechner United Kingdom
H. Weidauer Germany
Karen Blessing United Kingdom
Philip Hykin United Kingdom
Sarah J. McMillan United Kingdom
Matt Lechner United Kingdom
Richard Moscicki
Citations per year, relative to Richard Moscicki Richard Moscicki (= 1×) peers Matt Lechner

Countries citing papers authored by Richard Moscicki

Since Specialization
Citations

This map shows the geographic impact of Richard Moscicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Moscicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Moscicki more than expected).

Fields of papers citing papers by Richard Moscicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Moscicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Moscicki. The network helps show where Richard Moscicki may publish in the future.

Co-authorship network of co-authors of Richard Moscicki

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Moscicki. A scholar is included among the top collaborators of Richard Moscicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Moscicki. Richard Moscicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruberg, Stephen J., F. Beckers, Peter K. Honig, et al.. (2023). Application of Bayesian approaches in drug development: starting a virtuous cycle. Nature Reviews Drug Discovery. 22(3). 235–250. 34 indexed citations
2.
Moscicki, Richard & P.K. Tandon. (2017). Drug-Development Challenges for Small Biopharmaceutical Companies. New England Journal of Medicine. 376(5). 469–474. 14 indexed citations
3.
Jarow, Jonathan P. & Richard Moscicki. (2017). Impact of Expanded Access on FDA Regulatory Action and Product Labeling. Therapeutic Innovation & Regulatory Science. 51(6). 787–789. 10 indexed citations
4.
Jarow, Jonathan P., et al.. (2016). Expanded Access of Investigational Drugs: The Experience of the Center of Drug Evaluation and Research Over a 10-Year Period. Therapeutic Innovation & Regulatory Science. 50(6). 705–709. 57 indexed citations
5.
Phillips, A. G., et al.. (2014). Proceedings of the 2013 CINP Summit: Innovative Partnerships to Accelerate CNS Drug Discovery for Improved Patient Care. The International Journal of Neuropsychopharmacology. 18(3). pyu100–pyu100. 6 indexed citations
6.
Alexander, Thomas H., Michael H. Weisman, Jennifer Derebery, et al.. (2009). Safety of High-Dose Corticosteroids for the Treatment of Autoimmune Inner Ear Disease. Otology & Neurotology. 30(4). 443–448. 60 indexed citations
7.
Harris, Jeffrey P., Michael H. Weisman, Jennifer Derebery, et al.. (2003). Treatment of Corticosteroid-Responsive Autoimmune Inner Ear Disease With Methotrexate. JAMA. 290(14). 1875–1875. 137 indexed citations
8.
Zabner, Joseph, Bonnie W. Ramsey, David P. Meeker, et al.. (1996). Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.. Journal of Clinical Investigation. 97(6). 1504–1511. 207 indexed citations
9.
Bloch, Donald B., et al.. (1995). Serum Antibodies to Heat Shock Protein 70 in Sensorineural Hearing Loss. Archives of Otolaryngology - Head and Neck Surgery. 121(10). 1167–1171. 65 indexed citations
11.
Welsh, Michael J., Alan E. Smith, Joseph Zabner, et al.. (1994). Cystic Fibrosis Gene Therapy Using an Adenovirus Vector: In Vivo Safety and Efficacy in Nasal Epithelium. Howard Hughes Medical Institute, Iowa City, IA. Human Gene Therapy. 5(2). 209–219. 50 indexed citations
12.
Moscicki, Richard. (1994). Serum Antibody to Inner Ear Proteins in Patients With Progressive Hearing Loss. JAMA. 272(8). 611–611. 151 indexed citations
13.
Kolaczynski, Jerzy W., Ruth Carter, Kenneth J. Soprano, Richard Moscicki, & Guenther Boden. (1993). Insulin binding and degradation by rat liver Kupffer and endothelial cells. Metabolism. 42(4). 477–481. 14 indexed citations
14.
Pandolfi, Franco, Livio Trentin, Jocelyne Martin, et al.. (1992). T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis. Clinical & Experimental Immunology. 89(2). 198–203. 15 indexed citations
15.
Moscicki, Richard, et al.. (1990). Anaphylaxis during induction of general anesthesia: Subsequent evaluation and management. Journal of Allergy and Clinical Immunology. 86(3). 325–332. 60 indexed citations
16.
Cabot, Richard C., Robert E. Scully, Eugene J. Mark, et al.. (1989). Case 11-1989. New England Journal of Medicine. 320(11). 718–728. 3 indexed citations
17.
Moscicki, Richard, et al.. (1988). 197 Corticosteroid (CS) response in idiopathic progressive sensorineural hearing loss (SNHL). Journal of Allergy and Clinical Immunology. 81(1). 217–217. 6 indexed citations
18.
Udall, John N., Richard Moscicki, F I Preffer, et al.. (1987). Flow Cytometry: A New Approach to the Isolation and Characterization of Kupffer Cells. Advances in experimental medicine and biology. 216A. 821–827. 30 indexed citations
19.
Lazarovits, A I, Richard Moscicki, J T Kurnick, et al.. (1984). Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.. The Journal of Immunology. 133(4). 1857–1862. 127 indexed citations
20.
Moscicki, Richard, Edward P. Amento, Stephen M. Krane, J T Kurnick, & R B Colvin. (1983). Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes.. The Journal of Immunology. 131(2). 743–748. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026